Mx-dnG1 Retroviral Vector

Mx-dnG1 Retroviral Vector Uses, Dosage, Side Effects, Food Interaction and all others data.

Rexin-G is a tumor-targeted, injectable retroviral vector carrying a mutant form of the cyclin G1 gene. It is under development by Epeius Biotechnologies for the potential treatment of metastatic cancer. It is also being investigated for preventing SARSCOV-2 viral entry.

Trade Name Mx-dnG1 Retroviral Vector
Generic Rexin G
Rexin G Other Names DeltaRex-G, DeltaRex-G Retroviral Vector Encoding a Cyclin G1 Inhibitor, Mx-dnG1 retroviral vector, retroviral expression vector bearing anti-cyclin G1 gene construct, Rexin-G
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Mx-dnG1 Retroviral Vector
Mx-dnG1 Retroviral Vector

How Mx-dnG1 Retroviral Vector works

Mx-dnG1 Retroviral Vector is a non-pathogenic entity that mimics SARS-COV2 by binding to receptors to gain entry into human cells. It is being investigated for preventing SARSCOV-2 viral entry, and also acts as an inhibitor of the cyclin G1 pathway.

Innovators Monograph

You find simplified version here Mx-dnG1 Retroviral Vector

*** Taking medicines without doctor's advice can cause long-term problems.
Share